AVI Presents Data Showing Antisense Compounds Inhibit Dengue Virus In Vitro
AVI BioPharma said this week that it has presented data from a preclinical study showing that the company’s antisense compounds are capable of inhibiting dengue virus.
AVI Presents Data Showing Antisense Compounds Inhibit Dengue Virus In Vitro
AVI BioPharma said this week that it has presented data from a preclinical study showing that the company’s antisense compounds are capable of inhibiting dengue virus.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.